![Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it](https://pbs.twimg.com/media/ErYhxpWVQAMJk1P.jpg)
Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it
![COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7135a3_VaxSafetyForChildren_IMAGE_02Sep2022_1200x675_1.jpg)
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR
![IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery](https://www.mdpi.com/ijms/ijms-24-01404/article_deploy/html/images/ijms-24-01404-g001.png)
IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
![Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The](https://www.thelancet.com/cms/attachment/27116734-900d-4f93-906c-61d126ea039b/gr1_lrg.jpg)
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The
![A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy](https://www.cell.com/cms/attachment/71e0677c-57e3-4f48-8ebf-b42c74b8c848/fx1_lrg.jpg)
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy
![Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development](https://www.frontiersin.org/files/Articles/974433/fimmu-13-974433-HTML-r1/image_m/fimmu-13-974433-g001.jpg)
Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
![Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40249-021-00878-5/MediaObjects/40249_2021_878_Figa_HTML.png)
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text
![A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-21037-2/MediaObjects/41467_2021_21037_Fig4_HTML.png)
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
![Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1b50e54c-826f-483e-99ae-7498698cfd92/gr1_lrg.jpg)